NQO1 and neoplasm: Based on preclinical studies, we hypothesised that a combination of elevated NQO1 and low catalase (a detoxifying enzyme) in tumour specimens—reported as an elevated NQO1/catalase ratio—would provide the most meaningful predictor of efficacy.36 However, we were not able to reliably quantify tissue catalase expression in the available clinical samples.